BioWorld Asia

Oct. 19, 2005

ExonHit, BioMérieux Expand Union In Cancer Diagnostics

PARIS - ExonHit Therapeutics SA and BioMérieux extended and expanded their research collaboration for developing new blood-based diagnostics for the early detection of cancers. (BioWorld International) Read More

BioInvent Raising SEK160M In Discounted Rights Offering

Marijuana Brain Receptors May Help Slow Brain Aging

Trigen Brings In £18.2M Via Second Round For TGN255

Amgen Weighs In On Europe's Guidelines For Biosimilar Drugs

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 24, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.